stockrowIDEXX Laboratories, Inc.
IDXX Healthcare Diagnostics & Research
IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +9.86%
- EPS
- +17.3%
- Free cash flow
- +17.6%
- Total debt
- −28.6%
Quarter to September 2026, against a year earlier
Follow IDXX
Alert me
IDEXX Laboratories, Inc. (IDXX) Shares outstanding
IDEXX Laboratories, Inc.'s shares outstanding at the end of fiscal 2025 was $81.0M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $79.0M. Over the past ten years it has ranged from $81.0M (fiscal 2025) to $93.6M (fiscal 2015) — the current reading is the lowest in ten years. IDEXX Laboratories, Inc. ranks 22nd of 49 Diagnostics & Research companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $81.0M | (2.67%) |
| FY2024 | $83.2M | (0.87%) |
| FY2023 | $84.0M | (0.74%) |
| FY2022 | $84.6M | (2.28%) |
| FY2021 | $86.6M | (0.17%) |
| FY2020 | $86.7M | (0.94%) |
| FY2019 | $87.5M | (1.05%) |
| FY2018 | $88.5M | (1.22%) |
| FY2017 | $89.6M | (1.45%) |
| FY2016 | $90.9M | (2.95%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $79.0M | (0.33%) |
| Jun 2026 | $79.3M | (1.06%) |
| Mar 2026 | $80.2M | (1.07%) |
| Dec 2025 | $81.0M | 0.43% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| A Agilent Technologies, Inc. compare | $283.0M |
| IQV IQVIA Holdings Inc. compare | $167.0M |
| ILMN Illumina, Inc. compare | $154.0M |
| NTRA Natera, Inc. compare | $144.1M |
| DGX Quest Diagnostics Incorporated compare | $112.0M |
| WAT Waters Corporation compare | $98.7M |
| LH Labcorp Holdings Inc. compare | $81.6M |
| IDXX IDEXX Laboratories, Inc. | $79.0M |
| MTD Mettler-Toledo International, Inc. compare | $20.0M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on IDXX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement